A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new electric current treatment for people with glaucoma to improve their vision and quality of life by stimulating underperforming parts of their eyes and brain.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment rtACS Stimulation?
Who Is on the Research Team?
Joel Schuman, MD, FACS
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants undergo baseline assessments to measure visual function and quality of life
Intervention
Participants receive transorbital alternating current stimulation (rtACS) or sham stimulation
Post-intervention
Participants undergo assessments to evaluate changes in visual function and quality of life
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- rtACS Stimulation
- Sham Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor